- Home
- / Nova Mentis Life Science
Nova Mentis Life Science
Stock Price
$0
2024-10-29
Market Capitalization
$830.6 K
2024-10-29
Nova Mentis Life Science Summary
Company Summary
- Overview
- Nova Mentis Life Science is a biotechnology company that provides psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders. It diagnoses and treats debilitating chronic conditions such as autism spectrum disorder and fragile X syndrome.
- Type
- Public
- Status
- Active
- Founded
- 2004
- Website
- https://www.novamentis.ca
- Cybersecurity rating
Table of Contents
Nova Mentis Life Science Financials
Summary Financials
- Revenue (Q1, 2026)
- $C134.0K
- Gross profit (Q1, 2026)
- $C62.0K
- Net income (Q1, 2026)
- ($C326.0K)
- Cash (Q1, 2026)
- $C1.1M
- EBIT (Q1, 2026)
- ($C317.0K)
- Enterprise value
- ($4.4K)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026